Doctors test if slower pain shots reduce addiction risk in cancer patients

NCT ID NCT04296305

Summary

This study aims to find the best way to give intravenous pain medicine to hospitalized cancer patients. Researchers are comparing whether giving the drug hydromorphone quickly over 2 minutes or slowly over 15 minutes provides better pain relief while lowering the risk of patients liking the drug's 'high' feeling too much. The trial involves 84 cancer patients with moderate to severe pain, testing both methods in a crossover design to gather evidence for safer pain management guidelines.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.